Sarah Kathryn Rouan, Director at Viking Therapeutics, Inc. (VKTX), bought 1,240 shares at $24.15 ($30K) on 2025-03-31, disclosed to the SEC on 2025-04-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VKTX | SELL | 2024-01-19 | $692K | — | Filing → |
| NAVB | BUY | 2019-05-21 | $5K | — | Filing → |